Pluri Inc. — Director's Dealing 2014

Jun 19, 2014

1 of 1

[zk1415142.xml]

06/19/2014 05:16 PM

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or STATEMENT OF CHANGES IN BENEFICIAL Form 5 obligations may continue. See OWNERSHIP Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average 0.5 burden hours per response

1. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to PLURISTEM THERAPEUTICS Issuer INC [ PSTI ] (Check all applicable)

2. Name and Address of Reporting Person[*]

(Check all applicable) X Director 10% Owner Other Officer (give (specify title below) below)

GERMAIN MARK 0001195498

1. Date of Earliest Transaction

(Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year) 133 CLINTON STREET 06/18/2014 (Street) 4. If Amendment, Date of Original Filed BROOKLYN NY 11201 (Month/Day/Year) (City) (State) (Zip)

1. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting X Person Form filed by More than One Reporting Person

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) 5. Amount 6. 7. Nature Date Execution Date, if Transaction or Disposed Of (D) (Instr. of Ownership of Indirect (Month/Day/Year) any Code (Instr. 3, 4 and 5) Securities Form: Beneficial (Month/Day/Year) 8) Beneficially Direct (D) Ownership Owned or Indirect (Instr. 4) Following (I) (Instr. Reported 4) (A) Transaction Code V Amount or Price (s) (Instr. 3 (D) and 4) Common Stock 06/18/2014 S 22,500 D $3.104 311,850 D Common Stock 06/18/2014 S 10,715 D $3.13 301,135 D Common Stock 06/18/2014 S 5,000 D $3.133 296,135 D Common Stock 06/18/2014 S 5,000 D $3.15 291,135 D Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of 2. 3. Transaction 3A. Deemed 4. 5. 6. Date Exercisable and 7. Title and 8. Price 9. Nu Derivative Conversion Date Execution Date, if Transaction Number Expiration Date Amount of of of Security or Exercise (Month/Day/Year) any Code (Instr. of (Month/Day/Year) Securities Derivative Deriva (Instr. 3) Price of (Month/Day/Year) 8) Derivative Underlying Security Secur Derivative Securities Derivative (Instr. 5) Benef Security Acquired Security (Instr. Owne (A) or 3 and 4) Follow Disposed Repo of (D) Trans (Instr. 3, (s) (In 4 and 5) Amount or Number Date Expiration of Code V (A) (D) Exercisable Date Title Shares

Explanation of Responses:

Remarks:

/s/ Mark Germain 06/19/2014

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.